Table 1 | Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 2000–2004 | Reports | Statistics and Surveillance | Topics

Home

About CDC

Press Room

A-Z Index

CDC en Español

CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 2000–2004

Table 1. Estimated numbers of cases of HIV/AIDS, by race/ethnicity, sex, transmission category, and age category, 2001–2004—35 areas with confidential name-based HIV infection reporting

View PDF


	Year of diagnosis
Transmission category	2001	2002	2003	2004
	White, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	7,134	7,359	7,211	7,808
Injection drug use	963	892	882	877
Male-to-male sexual contact and injection drug use	552	597	579	636
High-risk heterosexual contact^a	588	599	625	633
Other^b	65	70	49	59
Subtotal	9,302	9,518	9,346	10,013

Female adult or adolescent
Injection drug use	593	544	500	530
High-risk heterosexual contact^a	1,276	1,236	1,197	1,229
Other^b	26	28	25	25
Subtotal	1,895	1,808	1,722	1,783

Total adults and adolescents	11,197	11,325	11,068	11,796

Child (<13 yrs)
Perinatal	37	23	30	8
Other^c	8	4	0	1
Subtotal	45	27	30	9
Total	11,242	11,352	11,097	11,806
	Black, not Hispanic
Male adult or adolescent
Male-to-male sexual contact	6,044	6,058	6,045	6,479
Injection drug use	2,808	2,451	2,255	2,053
Male-to-male sexual contact and injection drug use	667	554	521	498
High-risk heterosexual contact^a	3,431	3,233	3,047	2,958
Other^b	102	77	87	73
Subtotal	13,052	12,373	11,955	12,061

Female adult or adolescent
Injection drug use	1,731	1,456	1,350	1,258
High-risk heterosexual contact^a	6,393	6,084	5,729	5,641
Other^b	141	123	140	119
Subtotal	8,264	7,662	7,219	7,017

Total adults and adolescents	21,317	20,036	19,174	19,078

Child (<13 yrs)
Perinatal	208	170	124	105
Other^c	31	31	12	23
Subtotal	239	201	136	129
Total	21,556	20,237	19,310	19,206
	Hispanic
Male adult or adolescent
Male-to-male sexual contact	3,118	3,128	3,222	3,568
Injection drug use	1,311	964	986	826
Male-to-male sexual contact and injection drug use	270	248	262	207
High-risk heterosexual contact^a	974	916	967	896
Other^b	35	33	36	26
Subtotal	5,707	5,289	5,472	5,523

Female adult or adolescent
Injection drug use	518	364	360	310
High-risk heterosexual contact^a	1,382	1,228	1,176	1,073
Other^b	36	33	37	26
Subtotal	1,935	1,624	1,573	1,410

Total adults and adolescents	7,642	6,913	7,045	6,933

Child (<13 yrs)
Perinatal	57	43	28	30
Other^c	15	7	4	7
Subtotal	72	51	33	37
Total	7,714	6,964	7,078	6,970
	Asian/Pacific Islander
Male adult or adolescent
Male-to-male sexual contact	130	145	194	206
Injection drug use	33	35	28	35
Male-to-male sexual contact and injection drug use	6	8	12	11
High-risk heterosexual contact^a	41	55	46	47
Other^b	11	3	5	1
Subtotal	221	246	284	300

Female adult or adolescent
Injection drug use	8	12	15	15
High-risk heterosexual contact^a	45	55	65	76
Other^b	3	3	2	3
Subtotal	56	70	82	94

Total adults and adolescents	277	316	365	394

Child (<13 yrs)
Perinatal	2	3	2	0
Other^c	0	0	0	0
Subtotal	2	3	2	0
Total	279	319	367	394
	American Indian/Alaska Native
Male adult or adolescent
Male-to-male sexual contact	79	90	75	94
Injection drug use	19	18	19	18
Male-to-male sexual contact and injection drug use	20	10	17	12
High-risk heterosexual contact^a	9	16	18	25
Other^b	0	0	1	0
Subtotal	127	134	130	150

Female adult or adolescent
Injection drug use	13	20	18	13
High-risk heterosexual contact^a	28	45	37	44
Other^b	2	0	2	0
Subtotal	44	66	56	57

Total adults and adolescents	171	199	187	207

Child (<13 yrs)
Perinatal	0	3	0	1
Other^c	0	0	0	0
Subtotal	0	3	0	1
Total	171	202	187	208
Total^d	41,270	39,280	38,188	38,730

Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.

Data include persons with a diagnosis of HIV infection, a diagnosis of HIV infection and a later diagnosis of AIDS, or concurrent diagnoses of HIV infection and AIDS.

Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only.


^a	Includes heterosexual contact with a person who is HIV infected, a male who engages in male-to-male sex, a person who injects drugs, has hemophilia or coagulation disorder, or is a transplant or transfusion recipient.
^b	Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
^c	Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
^d	Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.

Last Modified: June 2, 2006
Last Reviewed: June 2, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Home

Policies and Regulations

Disclaimer

e-Government

FOIA

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.

Department of Health
and Human Services